Flunitong 5

Each ml contains Flunixin (as flunixin meglumine) 50 mg.

Horse: Indicated for the alleviation of inflammation and pain associated with musculoskeletal disorders, it is also indicated for the alleviation of visceral pain associated with colic.
Cattle: Indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis, it is also indicated for the control of inflammation in endotoxemia.

For intravenous administration to cattle and horses.
HORSES
For use in musculo-skeletal disorders, the recommended dose is 1.1mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight, once daily for up to 5 days according to clinical response.
For use in equine colic, the recommended dose is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight. Treatment may be repeated once or twice if colic recurs.

The recommended dose is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.

Do not exceed the recommended dose or the duration of treatment.
Do not administer to pregnant mares.
Do not administer to pregnant sows, gilts at mating and in breeding boars.
Do not administer to animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
Do not use in dehydrated animals suffering from ileus-associated colics.
Do not use the product within 48 hours before expected parturition in cows.

Flunixin meglumine is a non steroidal anti-inflammatory drug(NSAID).
Untoward effects include gastrointestinal irritation, ulceration and, in dehydrated or hypovolaemic animals, potential for renal damage.
Rare cases of anaphylactic reaction have been reported. In horses (rare) and cattle (very rare) anaphylaxis type reactions can include neurological signs such as convulsion, loss of consciousness and ataxia. Such reactions may be exacerbated by intra-arterial injection.

Avoid intra-arterial injection.
Do not use in piglets weighing less than 6 kg.
It is preferable that NSAIDs, which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered.
Since many NSAIDs possess the potential to produce gastrointestinal ulceration, concomitant use of flunixin meglumine with other anti-inflammatory drugs, such as other NSAIDs and corticosteroids, should be avoided.
Concurrent administration of potentially nephrotoxic drugs should be avoided.

Cattle: Meat & offal: 4 days; Milk: 36 hours
Not for use in horses intended for food.

Store in cool and dry place below 30°С. Protect from light.

Available in 50ml and 100ml bottle.

3 years.